Association. Innovation in Medicines PDA: A Global. and Manufacturing. David Tainsh, GSK Keith Pugh, MHRA

Size: px
Start display at page:

Download "Association. Innovation in Medicines PDA: A Global. and Manufacturing. David Tainsh, GSK Keith Pugh, MHRA"

Transcription

1 Innovation in Medicines PDA: A Global and Manufacturing Association David Tainsh, GSK Keith Pugh, MHRA Joint Regulators/Industry QbD Workshop January 2014 London, UK

2 Introduction Current State We have heard a lot about the challenges and successes of applying QbD Aside from Biopharms which we know are complex, Immediate Release Products are just the tip of the iceberg and we need to be more innovative if we are to be successful in delivering consistent and reliable quality for all products. Future State So before we close this workshop we just wanted to reflect on some of the new challenges facing us, what could be different and to ask how do you see it? 2

3 Challenges to Innovation Current Levels of Technical Capability Availability of New Skillsets Unwillingness to Deploy New Technology Large Investment in the Current State Perceptions of High Regulatory Hurdles Lack of Process to Manage Complex LCM Changes Lack of an Overall Vision on How to Modernise Pharmaceutical Manufacture 3

4 Opportunities for Innovation Novel Product Types for QbD More Complex Traditional Medicines Prolonged release Oral, Inhaled DPI, Nanoparticulates Novel products Advanced Therapeutics, Oligonucleotides, Microneedles Novel Methods of Manufacture & Control Continuous Synthetic Biochemistry - Biotransformations Discrete Manufacture & Novel Analytics Others? 4

5 Continuous Manufacturing: - Enabling Things Batch Can t Do Benefitting - Quality for Patients, - Environment - Business Process Shorter End to End Process Times Faster, Lower Cost Development More Process Understanding Factory Lower Work In Progress Costs Safer More Scale Independent Business Reliable Consistency Volume Flexibility Sustainable & Greener

6 Synthetic Biochemistry Moving to Microbial Cell Factories Greener, Cleaner, Cheaper - No solvents, fewer reagents - Fewer isolations & by-products - Aqueous based benign waste Biotransformations can be very specific in terms of chirality, position and functional group. Chemoenzymatic Approach Cascade Synthesis Enzyme Enzyme

7 Liquid Dispensing Technology Platform Industrial scale machine installed to provide Phase 3 and Launch Capability Capacity: 1 million tablets/day, upgradable to 2 million/day 7

8 Manufacturing - A Paradigm Shift Mfg.. Batch Mfg.. Discrete Units Population of Many Quality assessed by sampling post manufacture Population of One Quality assessed on-line for every tablet 8

9 Liquid Dispensing Technology with PAT UV / NIR [suspension concentration] 1. Vision system, droplet size 2. Droplet weight 1. Image analysis 2. NIR Chemical Imaging IR or Microwave Drug Solution or Suspension + Placebo Tablets Low Volume (c. 2-20ul) Dispensing Drying On-Line Analysis Chemical Imaging Surface Coating & Printing No Linkage between First and Last Tablet 9

10 Process Analytical Technologies Video Image of Droplet: What was Delivered NIR Chemical Imaging: Where on the Tablet 10

11 Comparison of Droplet Content Uniformity vs Typical 2mg Tablet Content Uniformity LSL -3.s +3.s USL E E E6 7E6 7.02E6 7.04E6 7.06E6 7.08E6 7.1E6 7.12E6 7.14E6 7.16E6 7.18E6 7.2E6 7.22E6 7.24E6 7.26E6 7.28E6 7.3E6 7.32E6 7.34E6 7.36E6 Frequency 11 85% Droplet N= 606 PpK =16 115% LSL -3.*S Nominal +3.*S USL Tablet N= 520 PpK =

12 100% Vision QC Inspection Control and Testing UV Solution Analysis Reticule Calibration Drop Volume/Dose Content Tunnel Temp. Conditions NIR Dose Position Inspection 100% Vision QC Inspection Incoming core tablet Dosing Drying Coating & Printing Wet Dose Position Inspection Droplet Weight Check Pad Inspection/ Coating Confirmation 12 System monitoring tablet shift register and rejection confirmation

13 Desired State A Vision to Modernise Pharmaceutical Manufacture Enabling Regulatory Strategy and Process that keeps pace with Innovation Increased Opportunities for Scientific Dialogue around innovative platforms Education and Training to Provide New Skillsets Enhanced scientific and risk based approaches to QbD to match new technologies A Simplified and Streamlined Variations Process 13

14 Challenges to Innovation Current Levels of Technical Capability Availability of New Skillsets Unwillingness to Deploy New Technology Large Investment in the Current State Perceptions of High Regulatory Hurdles Lack of Process to Manage Complex LCM Changes Lack of an Overall Vision on How to Modernise Pharmaceutical Manufacture 14

15 Desired State A Vision to Modernise Pharmaceutical Manufacture - Industry driven Enabling Regulatory Strategy and Process that keeps pace with Innovation Facilitate within existing Regulation 15

16 Desired State Increased Opportunities for Scientific Dialogue around innovative platforms - Scientific Advice (EMA/NCA) - Working Parties e.g. QWP, BWP - PAT team - early interactions recommended Education and Training to Provide New Skillsets - Should also include Regulators 16

17 Desired State Enhanced scientific and risk based approaches to QbD to match new technologies - Apply and build on existing learning A Simplified and Streamlined Variations Process - EU legislation (Common system since August 2013) - Changes already classified on a risk based basis - Detailed classification guideline 17

18 Summary - Types of Variations Changes not requiring any prior approval Changes requiring prior approval Design Space No submission required if within an approved design space Type IA Do & tell Type IB (Default) Tell, wait & do Variations Type II Extension Evaluation Procedure adapted to the level of risk

19 Desired State A Simplified and Streamlined Variations Process - EU - Changes already classified on a risk based basis - Additional flexibility Post Approval Change Management Protocol (PACMP) - justify downgrading in type of required variation - no restrictions to the nature of changes - limit (Type IB) regarding level of downgrading for biopharmaceutical products. - Global challenges - What do you want? 19

20 Conclusion By No Means a Comprehensive View of the Challenges Facing All of Us or the Possible Solutions But a Stimulus for Further Discussion So How do you See the future Challenges and Opportunities for Innovation? 20

GSK s Development of Novel Oral Delivery Technologies Perspectives

GSK s Development of Novel Oral Delivery Technologies Perspectives GSK s Development of Novel Oral Delivery Technologies Perspectives Mark Wilson Director, PTS, R&D GlaxoSmithKline Pharmaceuticals GSK Established a Technology Incubator To Develop Drug Delivery Systems

More information

Q8 and Q8 annex An industry Perspective

Q8 and Q8 annex An industry Perspective Workshop on Implementation of ICH Q8/Q9/Q10 and Other Quality Guidelines Beijing December 2008 Q8 and Q8 annex An industry Perspective Brian Withers, Abbott Laboratories, United Kingdom I attend this conference

More information

Challenges of Implementation of ICH Q 8

Challenges of Implementation of ICH Q 8 Challenges of Implementation of ICH Q 8 A Regulatory Perspective Dr. Susanne Keitel BioKorea, Seoul, September 2007 Overview of the Presentation ICH Q 8: Background; EU Experience Design Space Associated

More information

Feedback EMEA / Industry Discussion

Feedback EMEA / Industry Discussion Feedback EMEA / Industry Discussion Eli Lilly & Co Ltd Case Study: Use of In-Line Near-Infrared Spectroscopy to Monitor Segregation of a Pharmaceutical Powder Blend in a Tablet Press Martin Diller PhD,

More information

Analytical Methods and Sampling in the New Manufacturing Paradigm a Regulatory Perspective

Analytical Methods and Sampling in the New Manufacturing Paradigm a Regulatory Perspective Analytical Methods and Sampling in the New Manufacturing Paradigm a Regulatory Perspective Dr. Øyvind Holte Norwegian Medicines Agency EMA PAT team/ EDQM PAT working party 15 October, 2014, Heidelberg

More information

Quality by Design and OINDP. Today s Presentation

Quality by Design and OINDP. Today s Presentation Quality by Design and OINDP Setting the Stage John C Berridge IPAC-RS September 2008 Today s Presentation QbD definition Setting the stage from an ICH perspective Future Opportunities 2 QbD Definition

More information

EU GMP Evolution or Revolution Scope and drivers for EU GMP changes. August Gordon Farquharson

EU GMP Evolution or Revolution Scope and drivers for EU GMP changes. August Gordon Farquharson EU GMP Evolution or Revolution Scope and drivers for EU GMP changes August 2015 Gordon Farquharson EU & PIC/S Harmonisation at IWG level now Slide 2 PharmOut 2015 EU & PIC/S Harmonisation (1) What does

More information

CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D.

CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D. CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D. Senior Scientist (for Quality) Pharmaceuticals and Medical Devices Agency (PMDA) MFDS Nov 11, 2016 1 Agenda Introduction of PMDA ICH Q12 QbD assessment

More information

STRATEGIES FOR SUCCESSFUL SCALE-UP USING QUALITY BY DESIGN

STRATEGIES FOR SUCCESSFUL SCALE-UP USING QUALITY BY DESIGN STRATEGIES FOR SUCCESSFUL SCALE-UP USING QUALITY BY DESIGN CHRISTOPHER J POTTER ISPE ADVISOR AND CMC CONSULTANT 1 AGENDA Background ICH Guidelines Terms and Definitions Supporting Information ISPE publications

More information

Workshop Guide. Joint Regulators/Industry QbD Workshop January 2014 London, UK. europe.pda.org/ema2014

Workshop Guide. Joint Regulators/Industry QbD Workshop January 2014 London, UK. europe.pda.org/ema2014 EMA together with other EU Health Agencies Joint Regulators/Industry QbD Workshop 28-29 January 2014 London, UK Workshop Guide europe.pda.org/ema2014 ORGANIZED BY PDA EUROPE Letter from the Chairs Dear

More information

PMDA perspective on Quality by Design for pharmaceutical products

PMDA perspective on Quality by Design for pharmaceutical products PMDA perspective on Quality by Design for pharmaceutical products Junichi Fukuchi, Ph.D. Office of Cellular and Tissue-based Products Pharmaceuticals and Medical Devices Agency (PMDA) Annual conference

More information

peace of mind For from development to commercial supply

peace of mind For from development to commercial supply For peace of mind from development to commercial supply aesica-pharma.com weshouldtalk@aesica-pharma.com @aesica CorporateBroEng_v2 0814 @ Aesica 2014 Your full service CDMO Our vision: To be the number

More information

Claus Mortensen, Medicines Inspector. Danish Medicines Agency. Member of the EMEA PAT team

Claus Mortensen, Medicines Inspector. Danish Medicines Agency. Member of the EMEA PAT team Claus Mortensen, Medicines Inspector Danish Medicines Agency Member of the EMEA PAT team EMEA progress and status what is needed to document scientific understanding in a PAT application EMEA PAT team

More information

Quality by Design, Clinical Relevance & Lifecycle Considerations

Quality by Design, Clinical Relevance & Lifecycle Considerations Quality by Design, Clinical Relevance & Lifecycle Considerations Robert Iser Acting Director Office of Process & Facilities / OPQ / CDER IFPAC 2016 1 FDA Quality Related Guidance and Initiatives Initiatives

More information

ICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective

ICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective 14 th DIA Japan Annual Meeting 2017 November 12-14, 2017 Tokyo Big Sight Ariake ICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective Yasuhiro Kishioka, Ph.D. Principal Reviewer Office

More information

Terrence Tougas. Dennis Sandell

Terrence Tougas. Dennis Sandell Terrence Tougas Boehringer Ingeheim, Ridgefield, CT Dennis Sandell S5 Consulting, Lund, Sweden (c) 2011 Sandell & Tougas 1 Transforming the general concept of Quality into objective, well defined and actionable

More information

Pharmaceutical Manufacturing and Engineering Catalog Excerpt

Pharmaceutical Manufacturing and Engineering Catalog Excerpt Pharmaceutical Manufacturing and Engineering Catalog Excerpt PME 530 Introduction to Pharmaceutical Manufacturing Pharmaceutical manufacturing is vital to the success of the technical operations of a pharmaceutical

More information

The Changing Face of Product and Process Development in the QbD Era. James Kraunsoe AstraZeneca Product Development UK/US

The Changing Face of Product and Process Development in the QbD Era. James Kraunsoe AstraZeneca Product Development UK/US The Changing Face of Product and Process Development in the QbD Era James Kraunsoe AstraZeneca Product Development UK/US Disclaimer The views and opinions expressed in the following PowerPoint slides are

More information

Foreign Particulate Matter testing using the Morphologi G3

Foreign Particulate Matter testing using the Morphologi G3 Foreign Particulate Matter testing using the Morphologi G3 Introduction The Morphologi G3 with its Foreign Particle Detection capabilities allows the detection, enumeration and size classification of foreign

More information

Inter-Association Task Force

Inter-Association Task Force Inter-Association Task Force Presentation to EMA Workshop Prevention of Drug Shortages Based on Quality and Manufacturing Issues 9 th October 2015 1 Topics for Today Background and history of task force

More information

Reflection Paper on synergies between regulatory and HTA issues. DG SANTE Unit B4 Medical products: safety, quality, innovation

Reflection Paper on synergies between regulatory and HTA issues. DG SANTE Unit B4 Medical products: safety, quality, innovation Reflection Paper on synergies between regulatory and HTA issues DG SANTE Unit B4 Medical products: safety, quality, innovation STAMP meeting, 28 June 2016 Outline Aim of the Reflection Paper Drafting process

More information

Value Paper. Are you PAT and QbD Ready? Get up to speed

Value Paper. Are you PAT and QbD Ready? Get up to speed Value Paper Are you PAT and QbD Ready? Get up to speed PAT and Quality-by-Design As PAT and Quality -by-design (QbD) become an integral part of the regulatory framework, automation group ABB argues more

More information

ConsiGma TM, a platform for continuous processing

ConsiGma TM, a platform for continuous processing ConsiGma TM, a platform for continuous processing GEA Pharma Systems Where Inspiration meets Technology GEA Process Engineering / GEA Pharma Systems ConsiGma TM R&D and Manufacturing platform ConsiGma

More information

25 th Workshop of the EURORDIS Round Table of Companies (ERTC)

25 th Workshop of the EURORDIS Round Table of Companies (ERTC) 25 th Workshop of the EURORDIS Round Table of Companies (ERTC) Healthcare Companies & European Reference Networks: Expectations & Potential for Collaboration Introduction Tuesday 26 September, 2017 (09:00

More information

STOA Workshop. New technologies and Regional Policy Towards the next Cohesion Policy framework. Industrial policy and investments for growth

STOA Workshop. New technologies and Regional Policy Towards the next Cohesion Policy framework. Industrial policy and investments for growth STOA Workshop New technologies and Regional Policy Towards the next Cohesion Policy framework Industrial policy and investments for growth Brussels, 16 October 2017 Dana Eleftheriadou Policy Coordinator

More information

Impact of ICH Q9 and the application of Risk Management

Impact of ICH Q9 and the application of Risk Management Safeguarding public health Impact of ICH Q9 and the application of Risk Management An inspector s perspective on the impact on inspectional approaches and expectations Ian Thrussell Strategy and Development

More information

Leader in Pharmaceutical Films

Leader in Pharmaceutical Films TSX-V: IGX OTCQX: IGXT Leader in Pharmaceutical Films Your Specialist in Contract Development & Manufacturing WE MAKE APPROVED DRUGS BETTER Our Mission We make approved drugs better, with next generation

More information

Office of Pharmaceutical Quality Key Quality Initiatives

Office of Pharmaceutical Quality Key Quality Initiatives Office of Pharmaceutical Quality Key Quality Initiatives Ashley B. Boam, MSBE Director Office of Policy for Pharmaceutical Quality Office of Pharmaceutical Quality Center for Drug Evaluation and Research

More information

Industrial Innovation Information Days Brussels 3-4 October 2017

Industrial Innovation Information Days Brussels 3-4 October 2017 Industrial Innovation Information Days Brussels 3-4 October 2017 NMBP Programme Parallel Sessions OPEN INNOVATION TEST BEDS Calls 2018/2019 Helene CHRAYE, HoU Unit D3 DG Research & Innovation A joint presentation

More information

Pharmaceutical Process Development

Pharmaceutical Process Development Announcing the following Seminar to be conducted by IVEPE-SEV Pharmaceutical Process Development Factors in Scale-Up, Process Validation and Regulatory Considerations Course Topics Include: Solid Dosage

More information

Progress in FDA s Drug Product Quality Initiative. Janet Woodcock, M.D. November 13, 2003

Progress in FDA s Drug Product Quality Initiative. Janet Woodcock, M.D. November 13, 2003 Progress in FDA s Drug Product Quality Initiative Janet Woodcock, M.D. November 13, 2003 Impetus for Initiative: Modernization and continuous improvement in pharmaceutical manufacturing sector slow compared

More information

Update on Lessons Learned from the EMA-FDA QbD Pilot

Update on Lessons Learned from the EMA-FDA QbD Pilot Update on Lessons Learned from the EMA-FDA QbD Pilot IFPAC 2014 Annual Meeting 22 January 2014 Sharmista Chatterjee, Ph.D. CMC Lead for QbD, ONDQA/OPS/CDER/FDA Background One of the projected outcomes

More information

the SPD company Dr Clive Simon, Principal, The SPD Company.

the SPD company Dr Clive Simon, Principal, The SPD Company. the SPD company With decades of local and international experience at the coalface, The SPD Company s specialists have built a solid repertoire of in-depth technical knowledge within the highly-regulated

More information

EDQM Conference. Quality of Medicines in a Globalised World: Dreams and Reality

EDQM Conference. Quality of Medicines in a Globalised World: Dreams and Reality EDQM Conference Quality of Medicines in a Globalised World: Dreams and Reality 14-15 October 2010 Prague, Czech Republic 2010 EDQM, Council of Europe, All rights reserved Plenary Session Dr Moheb M. Nasr

More information

Importance of ICH Guidance in Fulfilling Process Validation Requirements

Importance of ICH Guidance in Fulfilling Process Validation Requirements Importance of ICH Guidance in Fulfilling Process Validation Requirements Presented by: Gamal Amer All rights reserved. Do not copy without permission. Principal 1 Premier Compliance Services, Inc. Process

More information

FT-IR.

FT-IR. FT-IR varian, inc. 610/620-IR ft-ir MICROSCOPY AND IMAGING SoLUTIONS www.varianinc.com VARIAN, INC. Setting the Standard Again When Only the Best Will Do The world leader in molecular spectroscopy innovation

More information

Requirements in Other Countries PQRI+USP EI Workshop; Rockville, MD, Dr. Helmut Rockstroh

Requirements in Other Countries PQRI+USP EI Workshop; Rockville, MD, Dr. Helmut Rockstroh Requirements in Other Countries PQRI+USP EI Workshop; Rockville, MD, 2015 Dr. Helmut Rockstroh Overview Introduction - Scope Pharmacopoeial + HA Positions Examples / Case Studies Discussion 2 Introduction:

More information

Progressive Licensing and the Modernization of the Canadian Regulatory Framework

Progressive Licensing and the Modernization of the Canadian Regulatory Framework Progressive Licensing and the Modernization of the Canadian Regulatory Framework Workshop on Implementation of ICH Quality Guidelines Beijing, China 3-5 December, 2008 Mike Ward Health Canada 1 DISCLAIMER

More information

The Effect of Coating Process Conditions and Coating Formula Type on the Quantity and Location of Water in Film Coated Tablets

The Effect of Coating Process Conditions and Coating Formula Type on the Quantity and Location of Water in Film Coated Tablets OPADRY II Application Data High Performance Film Coating System The Effect of Coating Process Conditions and Coating Formula Type on the Quantity and Location of Water in Film Coated Tablets OBJECTIVES

More information

EDQM Conference. Quality of Medicines in a Globalised World: Dreams and Reality

EDQM Conference. Quality of Medicines in a Globalised World: Dreams and Reality EDQM Conference Quality of Medicines in a Globalised World: Dreams and Reality 14-15 October 2010 Prague, Czech Republic 2010 EDQM, Council of Europe, All rights reserved Dr Georges France Ms Suzette Kox

More information

PDA 71 Years of Connecting People, Science and Regulation

PDA 71 Years of Connecting People, Science and Regulation PDA 71 Years of Connecting People, Science and Regulation 1 I m happy to be here. Bom Dia. Estou feliz por estar aqui. Richard M. Johnson PDA President & CEO since 2009 38 years experience in US and International

More information

Quality by Design. Innovate Design Development Create value. Correct definition of QbD and its relation to product and process development

Quality by Design. Innovate Design Development Create value. Correct definition of QbD and its relation to product and process development Innovate Development Create value Quality by Correct definition of QbD and its relation to product and process development Dr John Loveluck 42 Technology Ltd +44 1480 302700 john.loveluck@42technology.com

More information

Health & Social Care Industrial Innovation

Health & Social Care Industrial Innovation Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging

More information

TECHNOLOGY TRANSFER:

TECHNOLOGY TRANSFER: TECHNOLOGY TRANSFER: AN INTERNATIONAL GOOD PRACTICE GUIDE FOR PHARMACEUTICALS AND ALLIED INDUSTRIES Mark Gibson Editor PDA Bethesda, MD, USA DHI Publishing, LLC River Grove, IL, USA 10 9 8 7 6 5 4 3 2

More information

Importance of SMEs in Greening the Economy in Georgia

Importance of SMEs in Greening the Economy in Georgia Importance of SMEs in Greening the Economy in Georgia EaP Green Ministry of Environment and Natural Resources Protection of Georgia February 12, 2015 Kiev, Ukraine Importance of Green Economy for Georgia

More information

Innovative Approaches to Pharmaceutical Development and Manufacturing Seminar Series

Innovative Approaches to Pharmaceutical Development and Manufacturing Seminar Series CAMO European Pharmaceutical Seminars Jan/Feb 2009 Innovative Approaches to Pharmaceutical Development and Manufacturing Seminar Series The Increasing Need of Multivariate Analysis for Process Understanding

More information

EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS

EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE 1992-2012: 20 YEARS OF EXPERIENCE 22-23 March 2012 EDQM, Strasbourg, France ABSTRACTS PLENARY SESSION, 22 March 2012 ABSTRACT 1.3 The Evolution

More information

CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals

CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals Lawrence X. Yu, Ph.D. Director (acting) Office of Pharmaceutical Science Food and Drug Administration IFPAC

More information

APX TM TWO-WAY RADIOS NORTH AMERICA REGION. MotorolaSolutions.com/Services

APX TM TWO-WAY RADIOS NORTH AMERICA REGION. MotorolaSolutions.com/Services APX TM TWO-WAY RADIOS NORTH AMERICA REGION MotorolaSolutions.com/Services PREMIER SERVICES MAXIMIZE PERFORMANCE AND REDUCE RISK The task of maintaining and supporting a large inventory of two-way radios

More information

The Process Analytical Technology Initiative: PAT and the Pharmacopeias

The Process Analytical Technology Initiative: PAT and the Pharmacopeias The Process Analytical Technology Initiative: PAT and the Pharmacopeias Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Science CDER, FDA EDQM Spring Conference, Cannes, 3-43 4 May 2004

More information

Implementing Quality Systems

Implementing Quality Systems Implementing Quality Systems CGMP By The Sea August 29, 2006 Chris Joneckis, Ph.D. Senior Advisor For CMC Issues Center For Biologics Evaluation And Research Add FDA Bar and Presentation Overview Driving

More information

IMI Revolutionising Europe s Pharmaceutical Industry. IMI Matters!

IMI Revolutionising Europe s Pharmaceutical Industry. IMI Matters! IMI Revolutionising Europe s Pharmaceutical Industry IMI Matters! Session in the Framework of the Event Joint Technology Initiatives Innovation in Action 4 6 October 2011 European Parliament Brussels Programme

More information

Mastering Environmental Monitoring

Mastering Environmental Monitoring pda.org/eu/em2019 2019 PDA EUROPE TRAINING Mastering Environmental Monitoring 15-16 OCTOBER 2019 WATTWIL, SWITZERLAND CONNECTING PEOPLE SCIENCE AND REGULATION Training & Education Program europe.pda.org

More information

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA EUnetHTA European network for Health Technology Assessment Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA University of Tokyo, October 24,

More information

Future of Pharmaceutical Quality and the Path to Get There

Future of Pharmaceutical Quality and the Path to Get There Future of Pharmaceutical Quality and the Path to Get There Lawrence Yu, Ph.D. Deputy Director, Office of Pharmaceutical Quality FDA Center for Drug Evaluation and Research INTERPHEX 2018, April 18, 2018,

More information

CPC Essentials I Part A Introduction to CPC Essentials and Patent Classification Systems

CPC Essentials I Part A Introduction to CPC Essentials and Patent Classification Systems CPC Essentials I Part A Introduction to CPC Essentials and Patent Classification Systems Classification Quality and International Cooperation (CQIC) Division Office of International Patent Cooperation

More information

ICH Q8, 9 & 10 and the Impact on the QP

ICH Q8, 9 & 10 and the Impact on the QP 1 ICH Q8, 9 & 10 and the Impact on the QP Peter H. Gough David Begg Associates phg@david-begg-associates.com 2 A New Approach to Regulation Approach to the regulation of pharmaceuticals is undergoing a

More information

Biomedical Innovation Has Science Overtaken the System?

Biomedical Innovation Has Science Overtaken the System? Adaptive Pathways for Transformative Medicinal Products. A New Paradigm with the Enhanced Application of Real-World Evidence? ISPOR 20 th Annual European Congress, Glasgow, Scotland Issue Panel 21, Wednesday,

More information

Our position. ICDPPC declaration on ethics and data protection in artificial intelligence

Our position. ICDPPC declaration on ethics and data protection in artificial intelligence ICDPPC declaration on ethics and data protection in artificial intelligence AmCham EU speaks for American companies committed to Europe on trade, investment and competitiveness issues. It aims to ensure

More information

The Power of Print in Laminated Card Manufacturing

The Power of Print in Laminated Card Manufacturing The Power of Print in Laminated Card Manufacturing ICMA EuroForum 2014-9 th / 10 th October Robin McMillan & John Schneiderhan working for you. Overview Current print processes and related inks Introduction

More information

Section heading. Strapline sub-heading

Section heading. Strapline sub-heading Section heading Strapline sub-heading Smart every time NextPharma stands out as your pharmaceutical development and manufacturing partner with fast, flexible and tailored solutions for markets worldwide

More information

Spectrum 400. FT-IR and FT-NIR Spectrometer. There is only one answer.

Spectrum 400. FT-IR and FT-NIR Spectrometer. There is only one answer. Spectrum 400 FT-IR and FT-NIR Spectrometer There is only one answer. The latest innovation in PerkinElmer s long history of IR technology leadership For over 60 years, PerkinElmer has been the world leader

More information

Mastering Environmental Monitoring

Mastering Environmental Monitoring pda.org/eu/em2019 2019 PDA EUROPE TRAINING Mastering Environmental Monitoring 15-16 OCTOBER 2019 WATTWIL, SWITZERLAND CONNECTING PEOPLE SCIENCE AND REGULATION Training & Education Program europe.pda.org

More information

Symposium on Continuous Manufacturing of Pharmaceuticals Notes

Symposium on Continuous Manufacturing of Pharmaceuticals Notes 1 2012 11 13 Symposium on Continuous Manufacturing of Pharmaceuticals Notes These are notes from the first open meeting regarding Novartis- MIT Center for Continuous Manufacturing (CCM). The meeting is

More information

Enpr EMA. Enpr-EMA. European Network of Paediatric Research at the European Medicines Agency

Enpr EMA. Enpr-EMA. European Network of Paediatric Research at the European Medicines Agency Enpr EMA European Network of Paediatric Research at the European Medicines Agency Enpr-EMA European Network of Paediatric Research at the European Medicines Agency An agency of the European Union Enpr

More information

Near-IR cameras... R&D and Industrial Applications

Near-IR cameras... R&D and Industrial Applications R&D and Industrial Applications 1 Near-IR cameras... R&D and Industrial Applications José Bretes (FLIR Advanced Thermal Solutions) jose.bretes@flir.fr / +33 1 60 37 80 82 ABSTRACT. Human eye is sensitive

More information

Training. Education CALENDAR FEDEGARI TECH CENTERS DM#407036

Training. Education CALENDAR FEDEGARI TECH CENTERS DM#407036 2016 CALENDAR COLLABORATION IN THE LIFE SCIENCES WORLD Valued customer, The need to increase efficiency and reliability in pharmaceutical manufacturing presents firms with unique opportunities to develop

More information

From API to Formulated Product

From API to Formulated Product From API to Formulated Product Jean-Marie Geoffroy, PhD Director, Product Development Takeda Global Research & Development 675 N Field Drive Lake Forest, IL 60045 jean-marie.geoffroy@tgrd.com Acknowledgments

More information

How Process Models can Facilitate Quality Risk Management for Emerging Technologies

How Process Models can Facilitate Quality Risk Management for Emerging Technologies How Process Models can Facilitate Quality Risk Management for Emerging Technologies Thomas O Connor, Ph.D. FDA-AIChE Workshop on Adopting Continuous Manufacturing North Bethesda, MD March 2 th, 2016 2

More information

KEY HIGHLIGHTS WORKSHOP 2019

KEY HIGHLIGHTS WORKSHOP 2019 KEY HIGHLIGHTS aenvironmental Monitoring afacility Design apractical Case Studies avisual Inspection aclean Room Behaviours aprocess Simulations arecent 483s, warning Letters and EU Observations WORKSHOP

More information

MEDIA RELEASE FOR IMMEDIATE RELEASE 4 JUNE 2014

MEDIA RELEASE FOR IMMEDIATE RELEASE 4 JUNE 2014 MEDIA RELEASE FOR IMMEDIATE RELEASE 4 JUNE 2014 A*STAR-HELLMA PARTNERSHIP TO INNOVATE MANUFACTURING PROCESSES Hellma Analytics, a leading company in optics analysis technologies, partners with A*STAR to

More information

CEOCFO Magazine. Pat Patterson, CPT President and Founder. Agilis Consulting Group, LLC

CEOCFO Magazine. Pat Patterson, CPT President and Founder. Agilis Consulting Group, LLC CEOCFO Magazine ceocfointerviews.com All rights reserved! Issue: July 10, 2017 Human Factors Firm helping Medical Device and Pharmaceutical Companies Ensure Usability, Safety, Instructions and Training

More information

Supporting Innovation through Regulation and Science

Supporting Innovation through Regulation and Science Supporting Innovation through Regulation and Science Larry O Dwyer, Scientific Affairs Manager PEARRL Regulatory Science Symposium 21 st June 2017, School of Pharmacy, UCC Overview of Presentation Drivers

More information

Lundbeck s view on the EU IP systems

Lundbeck s view on the EU IP systems Lundbeck s view on the EU IP systems Forårsmøde IPR in the EU May 26 2011 H. Lundbeck A/S 1 Agenda The Innovative Pharmaceutical Industry and why IP is so important for Lundbeck Lundbeck s wish list for

More information

IGDRP Mission, Scope, How it works

IGDRP Mission, Scope, How it works IGDRP Mission, Scope, How it works IGDRP-EDQM Workshop Strasbourg, France 13 May 2016 Dr. Craig Simon Associate Director, Bureau of Pharmaceutical Sciences Therapeutic Products Directorate Health Canada

More information

ASEPTIC PROCESSING, TODAY AND FUTURE

ASEPTIC PROCESSING, TODAY AND FUTURE ASEPTIC PROCESSING, TODAY AND FUTURE Dublin, Ireland, 4 October 2018 Marco Delgado Rueda ALL RIGHTS RESERVED 2018 PAREXEL INTERNATIONAL CORP. AGENDA Today s Reality and Needs Issues and Probable Causes

More information

EU s Innovative Medical Technology and EMA s Measures

EU s Innovative Medical Technology and EMA s Measures EU s Innovative Medical Technology and EMA s Measures 27 October 2017 Summit symposium 25-27 October 2017, Kyoto, Japan Presented by Guido Rasi Executive Director, European Medicines Agency (EMA) An agency

More information

USP Research & Innovation Program

USP Research & Innovation Program USP Research & Innovation Program Ding Ming, Ph.D. Vice president, Research & Innovation United States Pharmacopeial Convention (USP) October 13, 2016 USP Programs and Products Impact Millions Worldwide

More information

Andalusian Agency for Health Technology Assessment (AETSA)

Andalusian Agency for Health Technology Assessment (AETSA) Andalusian Agency for Health Technology Assessment (AETSA) Seville, 22 nd of July, 2016 Comments on the concept paper Facilitating the translation of advanced therapies to patients in Europe 1 Introduction

More information

Medicines Manufacturing in the UK 2017

Medicines Manufacturing in the UK 2017 Medicines Manufacturing in the UK 2017 Moderator: Magda Papadaki, PhD Head of Manufacturing Innovation The Association of the British Pharmaceutical Industry Medicines Manufacturing Industry Partnership

More information

Peter Gregory Managing Director, Publishing Royal Society of Chemistry

Peter Gregory Managing Director, Publishing Royal Society of Chemistry Society Publishing and Open Access Peter Gregory Managing Director, Publishing Royal Society of Chemistry My Background Ph.D. Chemist Post-doc research in Germany Ca. 20 papers published Associate Editor

More information

FDA s Evolving Approach to Pharmaceutical Quality

FDA s Evolving Approach to Pharmaceutical Quality FDA s Evolving Approach to Pharmaceutical Quality Lawrence Yu, Ph.D. Deputy Director, Office of Pharmaceutical Quality FDA Center for Drug Evaluation and Research 10th Annual FDA Inspections Summit Nov.

More information

Recent Trend of Generic Medicines Market In Japan

Recent Trend of Generic Medicines Market In Japan Recent Trend of Generic Medicines Market In Japan Joint 22 nd EGA and 19 th IGBA Annual Conference Dubrovnik, Croatia 9 June, 2016 Itsuro Yoshida President of Japan Generic Medicines Association Copyright

More information

Measurement & Control Technology

Measurement & Control Technology Measurement & Control Technology For process and laboratory analysis s Material properties s Colour measurement s Radiation measurement s Moisture measurement (NIR, microwave & RF) s Refractometers M.C.

More information

ABOUT THE MINISTERIAL PROGRAMME

ABOUT THE MINISTERIAL PROGRAMME Official Sponsor 1 2 ABOUT THE MINISTERIAL PROGRAMME The Ministerial Programme at Mobile World Congress is an influential forum offering senior government representatives an opportunity to expand their

More information

Pharmaceutical Patents and Evergreening. Jürgen Dressel Head of Global Patent Litigation Strategy, Novartis Pharma FICPI 2015, Cape Town, 14 Apr 2015

Pharmaceutical Patents and Evergreening. Jürgen Dressel Head of Global Patent Litigation Strategy, Novartis Pharma FICPI 2015, Cape Town, 14 Apr 2015 Pharmaceutical Patents and Evergreening Jürgen Dressel Head of Global Patent Litigation Strategy, Novartis Pharma FICPI 2015, Cape Town, 14 Apr 2015 Originator My personal views 2 Pharmaceutical Patents

More information

Submission of comments on Review of the Variations Guidelines (EC 1234/2008)

Submission of comments on Review of the Variations Guidelines (EC 1234/2008) 12 July 2012 Submission of comments on Review of the Variations Guidelines (EC 1234/2008) Comments from: Name of organisation or individual Leem Please note that these comments and the identity of the

More information

Process Analytical Technology (PAT): A Real Time Quality Assurance

Process Analytical Technology (PAT): A Real Time Quality Assurance Review Article Process Analytical Technology (PAT): A Real Time Quality Assurance Punita Raj, N. Vishal Gupta* Pharmaceutical Quality Assurance group, JSS College of Pharmacy, JSS University, Sri Shivarathreeshwara

More information

Model Based Design Of Medical Devices

Model Based Design Of Medical Devices Model Based Design Of Medical Devices A Tata Elxsi Perspective Tata Elxsi s Solutions - Medical Electronics Abstract Modeling and Simulation (M&S) is an important tool that may be employed in the end-to-end

More information

Decision regarding PHARMAC s Implementation of Trans-Pacific Partnership (TPP) provisions and other Amendments to Application Processes

Decision regarding PHARMAC s Implementation of Trans-Pacific Partnership (TPP) provisions and other Amendments to Application Processes 8 December 2016 Decision regarding PHARMAC s Implementation of Trans-Pacific Partnership (TPP) provisions and other Amendments to Application Processes PHARMAC is pleased to announce that changes will

More information

Health Care Ltd 3M United Kingdom PLC Every day, 3M people find new ways to make amazing things happen. Wherever they are, whatever they do, the company s customers know they can rely on 3M to help make

More information

Challenges, benefits, case study

Challenges, benefits, case study hallenges, benefits, case study Pharmaceutical development phases overview The new paradigm for development: Quality by Design (QbD) hallenges Benefits ase study losure and Q&A»»»»»» D. eriani Meet MINITAB,

More information

18th World Conference on Non-destructive Testing, April 2012, Durban, South Africa

18th World Conference on Non-destructive Testing, April 2012, Durban, South Africa 18th World Conference on Non-destructive Testing, 16-20 April 20, Durban, South Africa Guided Wave Testing for touch point corrosion David ALLEYNE Guided Ultrasonics Ltd, London, UK; Phone: +44 2082329102;

More information

Institute of Physical and Chemical Research Flowcharts for Achieving Mid to Long-term Objectives

Institute of Physical and Chemical Research Flowcharts for Achieving Mid to Long-term Objectives Document 3-4 Institute of Physical and Chemical Research Flowcharts for Achieving Mid to Long-term Objectives Basic Research Promotion Division : Expected outcome : Output : Approach 1 3.1 Establishment

More information

The New Delhi Communiqué

The New Delhi Communiqué India-EU Ministerial Science Conference 7-8 February 2007, New Delhi The New Delhi Communiqué BACKGROUND TO CONFERENCE At their Summit in Helsinki in October 2006, the leaders of the EU and India reiterated

More information

NHS Next Stage Review: Innovation

NHS Next Stage Review: Innovation NHS Next Stage Review: Innovation January 2008 Introduction 1. The Academy of Medical Sciences welcomes the opportunity to contribute to the NHS Next Stage Review. In this short response we have focused

More information

The future of work. Artificial Intelligence series

The future of work. Artificial Intelligence series The future of work Artificial Intelligence series The future of work March 2017 02 Cognition and the future of work We live in an era of unprecedented change. The world s population is expected to reach

More information

VisioNIR. High Speed NIR Spectrometer for 100% Process Inspection

VisioNIR. High Speed NIR Spectrometer for 100% Process Inspection VisioNIR High Speed NIR Spectrometer for 100% Process Inspection Table of Content Introduction... 2 visiotec VisioNIR High Speed NIR Spectrometer: Your Way to PAT... 2 The benefits of the VisioNIR system...

More information

Ultrasensitive LC MS/MS: Agilent 6470 and 6495 LC-QQQ

Ultrasensitive LC MS/MS: Agilent 6470 and 6495 LC-QQQ Ultrasensitive LC MS/MS: Agilent 6470 and 6495 LC-QQQ ROCK SOLID Performance for Trace-Level Quantitation Agilent Technologies 1 Brief History of Agilent 6400 QQQ LC/MS 6410 2006 6460 Agilent Jet Stream

More information

SECOND GLOBAL SYMPOSIUM ON HEALTH SYSTEMS RESEARCH SCIENCE TO ACCELERATE UNIVERSAL HEALTH COVERAGE

SECOND GLOBAL SYMPOSIUM ON HEALTH SYSTEMS RESEARCH SCIENCE TO ACCELERATE UNIVERSAL HEALTH COVERAGE SECOND GLOBAL SYMPOSIUM ON HEALTH SYSTEMS RESEARCH SCIENCE TO ACCELERATE UNIVERSAL HEALTH COVERAGE Beijing, 31 October - 3 November 2012 Background The Second Global Symposium on Health Systems Research

More information